TransCode Therapeutics, Inc.
RNAZ
$1.78
-$0.11-5.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.83M | -40.36M | -34.66M | -27.13M | -24.60M |
| Total Depreciation and Amortization | 97.40K | 86.90K | 114.20K | 192.30K | 315.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.04M | 16.06M | 15.02M | 11.80M | 11.59M |
| Change in Net Operating Assets | 4.09M | 2.82M | 15.60K | 617.30K | -1.66M |
| Cash from Operations | -22.61M | -21.40M | -19.52M | -14.52M | -14.35M |
| Capital Expenditure | -6.70K | -6.70K | -6.70K | -500.00 | -13.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.20K | 2.20K | 2.20K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.40K | -4.40K | -4.40K | -500.00 | -13.40K |
| Total Debt Issued | 950.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 8.85M | 15.94M | 18.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 22.67M | 22.67M | 22.67M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -455.70K | -- |
| Cash from Financing | 23.62M | 22.67M | 31.52M | 15.48M | 18.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.01M | 1.27M | 12.00M | 960.10K | 4.02M |